» Articles » PMID: 8953101

In Vitro Activity of Quinolones and Other Antimicrobial Agents Against Anaerobic Bacteria

Overview
Journal Clin Infect Dis
Date 1996 Dec 1
PMID 8953101
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The in vitro activities of ciprofloxacin, ofloxacin, sparfloxacin, and DU-6859a against peptostreptococci, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, Porphyromonas, Prevotella, and Fusobacterium were determined by an agar dilution method. These activities were compared with those of piperacillin/tazobactam, cefoxitin, imipenem, clindamycin, and metronidazole. Imipenem, metronidazole, and DU-6859a were the most active antimicrobial agents that were tested. The in vitro activity of DU-6859a was superior to those of ciprofloxacin, lomefloxacin, ofloxacin, and sparfloxacin.

Citing Articles

Optimising the treatment for uncomplicated acute appendicitis (OPTIMA trial): a protocol for a multicentre, randomised, double-blinded placebo-controlled study.

Wu J, Jiang H, Li S, Wu X, Wang P, Sawyer R BMJ Open. 2022; 12(5):e057793.

PMID: 35501082 PMC: 9062814. DOI: 10.1136/bmjopen-2021-057793.


Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.

Charrier C, Salisbury A, Savage V, Duffy T, Moyo E, Chaffer-Malam N Antimicrob Agents Chemother. 2017; 61(5).

PMID: 28223393 PMC: 5404544. DOI: 10.1128/AAC.02100-16.


Antimicrobial Susceptibility of Enteric Gram Negative Facultative Anaerobe Bacilli in Aerobic versus Anaerobic Conditions.

DeMars Z, Biswas S, Amachawadi R, Renter D, Volkova V PLoS One. 2016; 11(5):e0155599.

PMID: 27191612 PMC: 4871507. DOI: 10.1371/journal.pone.0155599.


Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia.

Fisher B, Shaklee Sammons J, Li Y, de Blank P, Seif A, Huang Y J Pediatric Infect Dis Soc. 2015; 3(4):329-35.

PMID: 26625453 PMC: 4854370. DOI: 10.1093/jpids/piu008.


The new fluoroquinolones: A critical review.

Zhanel G, Walkty A, Vercaigne L, Karlowsky J, Embil J, Gin A Can J Infect Dis. 2012; 10(3):207-38.

PMID: 22346384 PMC: 3250697. DOI: 10.1155/1999/378394.